Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Alx Oncology Holdings Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 61 | 61 | 0 |
| Shares | 29.1M | 27.8M | −1.29M (−4.4%) |
| Value | $12.1M | $50.8M | +$38.7M (+320.9%) |
New holders (8)
Institutions that held Alx Oncology Holdings Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Driehaus Capital Management LLC | 795,777 | $1.46M | 0.01% |
| Ameriprise Financial Inc | 652,897 | $1.19M | 0.00% |
| Ieq Capital, LLC | 92,233 | $168.8K | 0.00% |
| Bridgeway Capital Management, LLC | 36,000 | $65.9K | 0.00% |
| HRT Financial LP | 22,535 | $41.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 8,025 | $14.7K | 0.00% |
| Optiver Holding B.V. | 28 | $51 | 0.00% |
| SRS Capital Advisors, Inc. | 2 | $3 | 0.00% |
Sold out (8)
Institutions that held Alx Oncology Holdings Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Tang Capital Management LLC | 3,158,265 | $1.31M |
| Charles Schwab Investment Management Inc | 133,433 | $55.4K |
| Squarepoint Ops LLC | 58,307 | $24.2K |
| Group One Trading, L.P. | 5,194 | $2.16K |
| Raymond James Financial Inc | 1,000 | $415 |
| Wells Fargo & Company | 447 | $186 |
| Clearstead Advisors, LLC | 177 | $74 |
| True Wealth Design, LLC | 15 | $7 |